Recent studies have indicated that HMGA2 and LINC00858 function as ceRNA to promote lung cancer progression and MTAT rs1061451 was a protective factor of non-small-cell lung cancer (NSCLC) [19–21]. Here, LINC00858 is linked to non-small cell lung carcinoma.